Fig. 3From: Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomesSurviving fraction and the IC50 of HCT-116 cells after 48 h treatment with a blank nano-cubosomes b cisplatin c cisplatin nano-cubosomes d metformin e cisplatin-metformin nano-cubosomes f IC30 cisplatin nano-cubosomes and different metformin concentrations. The actual data represent the mean ± SD of 3 separate experiments performed in sextupletsBack to article page